-
1دورية أكاديمية
المؤلفون: Thieblemont, C, Phillips, T, Ghesquieres, H, Cheah, CY, Clausen, MR, Cunningham, D, Do, YR, Feldman, T, Gasiorowski, R, Jurczak, W, Kim, TM, Lewis, DJ, van der Poel, M, Poon, ML, Cota Stirner, M, Kilavuz, N, Chiu, C, Chen, M, Sacchi, M, Elliott, B, Ahmadi, T, Hutchings, M, Lugtenburg, PJ
المساهمون: Cunningham, David
جغرافية الموضوع: United States
وصف الملف: Print-Electronic; application/pdf
العلاقة: Journal of Clinical Oncology, 2022, pp. JCO2201725 -; https://repository.icr.ac.uk/handle/internal/5717Test
الإتاحة: https://doi.org/10.1200/JCO.22.01725Test
https://repository.icr.ac.uk/handle/internal/5717Test -
2دورية أكاديمية
المؤلفون: Zinzani P. L., Ramchandren R., Santoro A., Paszkiewicz-Kozik E., Gasiorowski R., Johnson N. A., de Oliveira J. S. R., Buccheri V., Perini G. F., Dickinson M., McDonald A., Ozcan M., Sekiguchi N., Zhu Y., Raut M., Saretsky T. L., Nahar A., Kuruvilla J.
المساهمون: Zinzani P.L., Ramchandren R., Santoro A., Paszkiewicz-Kozik E., Gasiorowski R., Johnson N.A., de Oliveira J.S.R., Buccheri V., Perini G.F., Dickinson M., McDonald A., Ozcan M., Sekiguchi N., Zhu Y., Raut M., Saretsky T.L., Nahar A., Kuruvilla J.
مصطلحات موضوعية: Quality-of-life, pembrolizumab, brentuximab vedotin, relapsed/refractory, Hodgkin lymphoma
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34644372; info:eu-repo/semantics/altIdentifier/wos/WOS:000754639300004; volume:6; issue:2; firstpage:590; lastpage:599; numberofpages:10; journal:BLOOD ADVANCES; https://hdl.handle.net/11585/904791Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85123548552; https://ashpublications.org/bloodadvances/article/6/2/590/477276/Quality-of-life-analysis-of-pembrolizumab-vsTest
الإتاحة: https://doi.org/10.1182/bloodadvances.2021004970Test
https://hdl.handle.net/11585/904791Test
https://ashpublications.org/bloodadvances/article/6/2/590/477276/Quality-of-life-analysis-of-pembrolizumab-vsTest -
3دورية أكاديمية
المؤلفون: Wong, J, Gruber, E, Maher, B, Waltham, M, Sabouri-Thompson, Z, Jong, I, Luong, Q, Levy, S, Kumar, B, Brasacchio, D, Jia, W, So, J, Skinner, H, Lewis, A, Hogg, SJ, Vervoort, S, DiCorleto, C, Uhe, M, Gamgee, J, Opat, S, Gregory, GP, Polekhina, G, Reynolds, J, Hawkes, EA, Kailainathan, G, Gasiorowski, R, Kats, LM, Shortt, J
العلاقة: pii: 10.1038/s41375-022-01571-8; Wong, J., Gruber, E., Maher, B., Waltham, M., Sabouri-Thompson, Z., Jong, I., Luong, Q., Levy, S., Kumar, B., Brasacchio, D., Jia, W., So, J., Skinner, H., Lewis, A., Hogg, S. J., Vervoort, S., DiCorleto, C., Uhe, M., Gamgee, J. ,. Shortt, J. (2022). Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma. LEUKEMIA, 36 (6), pp.1654-1665. https://doi.org/10.1038/s41375-022-01571-8Test.; http://hdl.handle.net/11343/309076Test
-
4دورية أكاديمية
المؤلفون: Zinzani, PL, Ramchandren, R, Santoro, A, Paszkiewicz-Kozik, E, Gasiorowski, R, Johnson, NA, de Oliveira, JSR, Buccheri, V, Perini, GF, Dickinson, M, McDonald, A, Ozcan, M, Sekiguchi, N, Zhu, Y, Raut, M, Saretsky, TL, Nahar, A, Kuruvilla, J
العلاقة: pii: 477276; Zinzani, P. L., Ramchandren, R., Santoro, A., Paszkiewicz-Kozik, E., Gasiorowski, R., Johnson, N. A., de Oliveira, J. S. R., Buccheri, V., Perini, G. F., Dickinson, M., McDonald, A., Ozcan, M., Sekiguchi, N., Zhu, Y., Raut, M., Saretsky, T. L., Nahar, A. & Kuruvilla, J. (2022). Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma. BLOOD ADVANCES, 6 (2), pp.590-599. https://doi.org/10.1182/bloodadvances.2021004970Test.; http://hdl.handle.net/11343/301626Test
-
5دورية أكاديمية
المؤلفون: Gasiorowski, R, Forbes, MK, Silver, G, Krastev, Y, Hamdorf, B, Lewis, B, Tisbury, M, Cole-Sinclair, M, Lanphear, BP, Klein, RA, Holmes, N, Taylor, MP
العلاقة: pii: 2790905; Gasiorowski, R., Forbes, M. K., Silver, G., Krastev, Y., Hamdorf, B., Lewis, B., Tisbury, M., Cole-Sinclair, M., Lanphear, B. P., Klein, R. A., Holmes, N. & Taylor, M. P. (2022). Effect of Plasma and Blood Donations on Levels of Perfluoroalkyl and Polyfluoroalkyl Substances in Firefighters in Australia: A Randomized Clinical Trial. JAMA Netw Open, 5 (4), pp.e226257-. https://doi.org/10.1001/jamanetworkopen.2022.6257Test.; http://hdl.handle.net/11343/307931Test
-
6دورية أكاديمية
المؤلفون: Shortt, J., Tan, S. Y., Cannell, P., Ng, T. F., Fong, C. Y., Ramanathan, S., Rajagopal, R., Leitch, S., Gasiorowski, R., Grove, C., Lenton, D., Tan, P., DiNardo, C., Ling, M. T., Cheng, S., Liu, Y., Co, M., Chan, W. Y., Simpson, D., Wei, A. H.
المصدر: HemaSphere ; volume 6, page 489-490 ; ISSN 2572-9241
-
7دورية أكاديمية
المؤلفون: Gregory, G., Timmerman, J., Lavie, D., Borchmann, P., Herrera, A. F., Minuk, L., Vucinic, V., Armand, P., Avigdor, A., Gasiorowski, R., Herishanu, Y., Keane, C., Kuruvilla, J., Palcza, J., Pillai, P., Marinello, P., Johnson, N. A.
المصدر: HemaSphere ; volume 6, page 976-977 ; ISSN 2572-9241
-
8دورية أكاديمية
المؤلفون: Morschhauser, F, Feugier, P, Flinn, IW, Gasiorowski, R, Greil, R, Illés, Á, Johnson, NA, Larouche, JF, Lugtenburg, Elly, Patti, C, Salles, GA, Trn?ný, M, de Vos, S, Mir, F, Samineni, D, Kim, SY, Jiang, Y, Punnoose, E, Sinha, A, Clark, E, Spielewoy, N, Humphrey, K, Bazeos, A, Zelenetz, AD
المصدر: Morschhauser , F , Feugier , P , Flinn , IW , Gasiorowski , R , Greil , R , Illés , Á , Johnson , NA , Larouche , JF , Lugtenburg , E , Patti , C , Salles , GA , Trn?ný , M , de Vos , S , Mir , F , Samineni , D , Kim , SY , Jiang , Y , Punnoose , E , Sinha , A , Clark , E , Spielewoy , N , Humphrey , K , Bazeos , A & Zelenetz , AD 2021 , ' ....
الإتاحة: https://doi.org/10.1182/blood.2020006578Test
https://pure.eur.nl/en/publications/ea526fb2-0622-46bb-b197-60d22d502c27Test
https://ashpublications.org/blood/article-pdf/137/5/600/1800528/bloodbld2020006578.pdfTest -
9دورية أكاديمية
المؤلفون: Zinzani, P. L., Raut, M., Saretsky, T., Ramchandren, R., Santoro, A., Paszkiewicz‐Kozik, E., Gasiorowski, R., Johnson, N. A., de Oliveira, J. S. R., Buccheri, V., Perini, G. F., Dickinson, M., McDonald, A., Ozcan, M., Sekiguchi, N., Giezek, H., Nahar, A., Kuruvilla, J.
المصدر: Hematological Oncology ; volume 39, issue S2 ; ISSN 0278-0232 1099-1069
-
10مؤتمر
المؤلفون: Karimi, Y, Ghesquieres, H, Jurczak, W, Cheah, CY, Clausen, MR, Lugtenburg, P, Cunningham, D, Do, YR, Lewis, DJ, Gasiorowski, R, Kim, TM, van der Poel, M, Poon, ML, Feldman, T, Linton, Kim M, Sureda, A, Hutchings, M, Stirner, MC, Liu, Y, Kilavuz, N, Sacchi, M, Thieblemont, C
المساهمون: The Christie NHS Foundation Trust and Manchester Cancer Research Centre, Manchester, United Kingdom.
العلاقة: Karimi Y, Ghesquieres H, Jurczak W, Cheah CY, Clausen MR, Lugtenburg P, et al. Longer Follow-Up Reaffirms Subcutaneous Epcoritamab Induces Deep and Durable Complete Remissions in Patients With Relapsed/Refractory Large B-Cell Lymphoma: Updated Results From the Pivotal EPCORE NHL-1 Trial. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2023 SEP;23:S438-S. PubMed PMID: WOS:001062479600463. English.; http://hdl.handle.net/10541/626739Test; Clinical Lymphoma Myeloma & Leukemia
النص الكامل